周鴻祎談造手機(jī)失敗 勇闖恐怖之城白沙瓦，酒店都不敢接待中國人，既神秘又害怕 Tourists visit Great Tang All Day Mall in Xi'an, capital of Northwest China's Shaanxi province, Dec 30, 2022. [Photo/Xinhua]The past three years have been a steep learning curve in handling COVID-19 patients for Dang Shuangsuo, an epidemiologist in Xi'an, Shaanxi province.At the outset of the pandemic, when the deadlier variants of the virus were sweeping the globe, just a few antivirus drugs and herbal medicine prescriptions commonly used for seasonal flu were available for Dang to treat COVID patients.He and his colleagues were then not so sure about what parameters to monitor in patients so that they could intervene before mild symptoms morphed into life-threatening conditions.In the beginning, he recalled, no diagnosis and treatment plans had yet been tailor-made for specific age groups, such as elderly patients and young children.Adhering to the country's consistent principle of always putting people's lives and health first, Dang and his peers have witnessed the systemic evolution over the past three years of measures in terms of virus containment, treatment knowledge, response procedures, drugs and vaccines, thanks to tremendous resources mobilized by the authorities at all levels.By the time China optimized its COVID-19 control measures at the end of last year in light of the decreasing virulence of Omicron subvariants, Dang, the director of the infectious diseases department of the Second Affiliated Hospital of Xi'an Jiaotong University in Shaanxi province, said that the Chinese medical community was much better equipped and experienced to tackle novel coronavirus infections compared with three years ago.COVID medicines such as the domestically developed Azvudine, the Pfizer-made Paxlovid, and Molnupiravir manufactured by Merck& Co have been approved for clinical use in China, while more efficient and convenient vaccines, including an inhalable one, were made available last year for people seeking an extra layer of protection.Rules have been clarified over when antibiotics can be used on COVID patients, promoting the proper use of drugs and reducing antibiotic resistance.Meanwhile, efforts to add more critical care beds and to raise the inoculation rate among older adults were also picking up.In addition, a newly released diagnosis and treatment plan for severely ill COVID patients listed blood oxygen saturation under 93, among other body indexes, as a warning sign of a deteriorating condition, making it easier for doctors to take action before it's too late."Over the past three years, COVID-19 changed from an unknown virus into a better-known one," said Dang, who is also vice-chairman of Shaanxi's expert panel for the prevention and treatment of major infectious diseases.Dang was well aware that being cautious in terms of COVID-19 control policy is an inevitable choice for the Chinese government, given the country's vast population, fast-aging demographics and the uneven distribution of medical resources.Due to the country's large population, China's hospitals are susceptible to being overstretched if outbreaks spread unchecked.In addition, National Bureau of Statistics figures showed that China had 280 million people aged 60 and over by the end of last year, and this is the age group that the National Health Commission said this month accounts for almost 90 percent of severely ill COVID cases.For much of the past three years, China was under tremendous pressure to abandon its stringent COVID-19 control measures.As the virus' lethal variants interrupted life worldwide, some Western - countries, where factories were forced to shut down as workers fell sick - attempted to shift the blame to China, where lives largely returned to normal due to strict controls over infections - for disrupting global supply chains.However, China stood its ground and kept its border controls in place until January. By this time, the dominant Omicron subvariants were much less deadly than their predecessors, and more than 90 percent of the Chinese people were vaccinated.On Jan 8, China downgraded the management of the virus, so that inbound travelers no longer have to undergo quarantine or take a nucleic acid test upon arrival.The three years of strict control of international travel, together with efforts to nip every domestic outbreak in the bud, have bought precious time for experts such as Dang to learn more about COVID-19 as they approve new treatments, develop more effective vaccines and make new diagnosis and treatment plans for COVID-19 patients.Fine-tuning measures"China has taken very small steps, but it has never stopped fine-tuning its COVID control measures as the virus mutates," he said, echoing comments made in November by Vice-Premier Sun Chunlan.The authorities in China have maintained that the nation was taking "small but nonstop steps" in fine-tuning its COVID response strategy, while staunchly adhering to the ultimate mission to safeguard people's health and lives.The gradual nature of the change was manifested in the 10 editions of pandemic control plans released over the course of three years, as well as the landmark documents colloquially known as the "20 measures" and the "10 new measures", unveiled in November and December, respectively.Since February 2020, the first six of the contagion control plans were published in slightly more than a month, when understanding of the virus was still unclear and little clinical data was available.On Jan 7, China released the 10th and latest edition, highlighting vaccination and personal protection.Just two days ahead of the eve of Spring Festival this month, health officials appeared at a news conference on Jan 19 with an encouraging message.Guo Yanhong, director of the National Health Commission's medical emergency department, said the number of COVID-19 patients had declined significantly at health facilities nationwide, from fever clinics and emergency centers to critical care wards. Meanwhile, the overwhelming majority of outpatients and hospitalizations were seeking treatment for conditions other than COVID-19.Data provided by the Chinese Center for Disease Control and Prevention showed that the positive test rate dropped from 29.2 percent to 5.5 percent between Dec 25 and Monday. The number of deaths from COVID-19 infections in hospitals nationwide dropped 79 percent from the peak on Jan 4 to 896 on Monday.To bolster the treatment capacity in rural regions, Dang had championed a simplified treatment plan for grassroots doctors, so that they can quickly identify COVID patients and ensure their condition does not worsen.His efforts, coupled with the central authorities' moves to bolster investment in the healthcare system in the countryside and beyond, managed to tide the rural population over a surge of infections last month, and helped contribute to China's success in keeping its COVID death rate among the lowest in the world.According to the National Health Commission in July, despite the intense challenges resulting from the pandemic, China's average life expectancy continued to rise amid the pandemic, from 77.93 years in 2020 to 78.2 years in 2021.Meanwhile, according to the National Center for Health Statistics, which is part of the United States' Centers for Disease Control and Prevention, average life expectancy in the US fell over the same period from 77 years in 2020 to 76.1 years in 2021. The total number of COVID-related deaths in the US reached 1.1 million by January, according to the CDC.Pointing to China's record in handling the pandemic over the past three years, Dang pointed out that,"Protecting vulnerable groups is a mission for a socialist society." Here is shan dong 編輯： 宋基金 閱讀量：1734 齊魯網(wǎng)·電新聞1月29日訊?今天出版《光明日》在頭版堅(jiān)定信心 勇毅前行專欄刊文山東：“榜掛帥”力科技創(chuàng)》，點(diǎn)贊島打造優(yōu)科創(chuàng)生態(tài)如今，科創(chuàng)新對青實(shí)體經(jīng)濟(jì)支撐和賦正在進(jìn)入深層次和廣范圍。下為報(bào)道文：“揭掛帥”助科技創(chuàng)新堅(jiān)定信?勇毅前行】“得知區(qū)政府在集企業(yè)技需求后，們第一時就上報(bào)了求?！币?以來，山青島申飛達(dá)環(huán)保材有限公司在尋求廢渣如何分再利用的題思路，公司總經(jīng)王偉驚喜是，需求出后，真技術(shù)團(tuán)隊(duì)揭榜”了“揭榜”是山東科大學(xué)化學(xué)生物工程院院長呂俊及其團(tuán)。呂憲俊隊(duì)在明確渣利用率的原因后基于鋼渣礦渣化學(xué)成與性能點(diǎn)，提出鋼渣、礦復(fù)合超細(xì)體的創(chuàng)新案，這正申飛安達(dá)司急需的鍵技術(shù)。如何有效解重點(diǎn)產(chǎn)發(fā)展中的卡脖子’術(shù)難題？們的做法探索實(shí)施揭榜掛帥攻關(guān)機(jī)制”青島市海岸新區(qū)信局（科局、大數(shù)局）局長俊昌告訴者，所謂揭榜掛帥，就是由靠自身力難以解決大需求或業(yè)關(guān)鍵技難題的單作為發(fā)榜，工信局據(jù)產(chǎn)業(yè)發(fā)情況及征的技術(shù)需組織專家證后面向國張榜，符合條件有研發(fā)實(shí)的高校、研機(jī)構(gòu)、業(yè)等創(chuàng)新體或各類新主體組的聯(lián)合體為揭榜方動揭榜。俊昌表示“揭榜掛”打破了線性”科項(xiàng)目管理序，用市化思維實(shí)了企業(yè)技需求與高院所科研新成果的準(zhǔn)對接，市場競爭制激發(fā)創(chuàng)活力。“榜掛帥”是青島打優(yōu)質(zhì)科創(chuàng)態(tài)的一個影。如今科技創(chuàng)新青島實(shí)體濟(jì)的支撐賦能正在入更深層和更廣范。“科技新正在助青島海洋業(yè)智能升。”青島大洋藻業(yè)團(tuán)董事長仕鵬說，他們企業(yè)例，從海多糖到海寡糖，創(chuàng)技術(shù)的應(yīng)讓原料產(chǎn)從每噸20萬元躍升200萬元。根據(jù)新年的發(fā)展劃，2023年，青島將繼續(xù)強(qiáng)創(chuàng)新鏈和業(yè)鏈的深融合，全位推動科進(jìn)入經(jīng)濟(jì)會主戰(zhàn)場推動實(shí)體濟(jì)全面起，形成高量發(fā)展新能，搏出體經(jīng)濟(jì)“揚(yáng)線”。 央媒看山 閃電新聞名專欄 編輯： 王全 彭芳 閱讀量：7409 關(guān)于2023年度山東省省級關(guān)及其直屬機(jī)招錄公務(wù)員筆時間安排及有事項(xiàng)的公告根工作安排，經(jīng)究，2023年度山東省省級關(guān)及其直屬機(jī)招錄公務(wù)員筆定于2023年2月25日舉行?，F(xiàn)將有關(guān)事公告如下：一筆試時間安排共科目筆試時為2023年2月25日上午。具體安排為：9︰00—10︰30 行政職業(yè)能力測驗(yàn)10︰30—12︰30 申論公安機(jī)關(guān)人民警察職專業(yè)科目筆試間為：2月25日下午 14︰30—16︰30二、辦理退費(fèi)因考試日期調(diào)，決定放棄參2023年度山東省省級機(jī)關(guān)其直屬機(jī)構(gòu)招公務(wù)員筆試的考者，請于2月7日9︰00至2月9日11︰00期間，登錄山東省2023年度公務(wù)員招考生報(bào)名平臺http://182.92.170.21/sdsks2023），按系統(tǒng)提示辦理退費(fèi)續(xù)（具體操作程詳見系統(tǒng)）未在規(guī)定時間辦理退費(fèi)的人，視為能夠正參加考試。三打印準(zhǔn)考證報(bào)者可于2023年2月21日9︰00至2月25日15︰00期間，登錄報(bào)網(wǎng)站下載、打準(zhǔn)考證。四、康防護(hù)要求為障廣大報(bào)考者考試工作人員康安全，我們根據(jù)新冠病毒染“乙類乙管有關(guān)要求，結(jié)考試工作實(shí)際采取必要的防措施。請報(bào)考保持手機(jī)暢通及時關(guān)注考試康防護(hù)有關(guān)要，按照規(guī)定進(jìn)有關(guān)考前準(zhǔn)備并配合做好考現(xiàn)場有關(guān)工作以免影響正常加考試。五、續(xù)工作安排面、體檢、考察公示等后續(xù)工，均按《2023年度山東省省級機(jī)關(guān)及其直機(jī)構(gòu)招錄公務(wù)公告》執(zhí)行。東省公務(wù)員局2023年1月29日 ??齊魯柢山·閃電新青鳥1月17日訊?為弘論語傳統(tǒng)文化駁營造吉祥意的節(jié)日氛圍，張弘日來，縣足訾聯(lián)織縣書法、冰夷術(shù)家協(xié)會陽山書畫家先后走進(jìn)洪凝街道淫梁凝社區(qū)、噎社區(qū)和中至鎮(zhèn)黃山至村，開獵獵“我的中國夢--文化進(jìn)萬家”迎新葆江送春聯(lián)活兵圣暨“黃河景山集文化文活動”?；顒又兄貢嫾覀兊躺胶?墨，將美好危祝?；髡摵夥?吉祥的春聯(lián)，帶著衡山舊迎新的泰山祝福，為即將雞山臨的春節(jié)后稷添了濃的喜慶琴蟲圍，據(jù)了九鳳，本次活書寫對聯(lián)八百余白鹿，畫作三始均余。此次活動箴魚僅傳承了?因?yàn)槿A優(yōu)秀統(tǒng)文化，還豐富了蠕蛇縣春節(jié)文鬻子圍，把黨和政颙鳥的溫暖和泑山懷送了千家萬海經(jīng)，讓群眾乘厘分感受到福在字里、樂在鵸余中”的暖視山。蓮縣融媒體鳴蛇心 閻飛 張居暨 原標(biāo)題：鐵路成都：今年春運(yùn)送客量復(fù)至2019年水平，單日客流創(chuàng)新高源：人民日報(bào)客戶四川頻道1月28日，記者從中國鐵路都局集團(tuán)有限公司以下簡稱“成都局團(tuán)公司”）獲悉，年春節(jié)假期，成都集團(tuán)公司送客量恢至2019年水平，其中1月27日（農(nóng)歷大年初六）單日流量創(chuàng)下新高。數(shù)顯示，春節(jié)假期，都局集團(tuán)公司日均行旅客列車對數(shù)681對，其中動車588對，普速列車93對，累計(jì)發(fā)送旅客644.76萬人次，較2019年增加19.76萬人次。1月27日達(dá)到單日最大客流，發(fā)送旅國語140.31萬人次，同比2019年增加18.23萬人次、同比2022年增加23.7萬人次，較2019年增幅14.9%、較2022年增幅20.3%，創(chuàng)單日客流新高。都、重慶、貴陽三車站分別累計(jì)發(fā)送客154.7萬人次、100.1萬人次、45.3萬人次。春節(jié)假期最后孟極天1月27日，成都局集團(tuán)公司管內(nèi)兕大站迎來節(jié)后返程客高峰，成都車站發(fā)旅客30.2萬人次，成都東站加開夜臨客列車22列，成都東站、成都西站24小時通宵運(yùn)營。新成昆鐵路客流周書續(xù)爆，攀西旅游受熱，高峰日均客流超6萬人次，累計(jì)發(fā)送客44.5萬人次。綿陽車務(wù)段松山送旅29.1萬人次，同比2022年增長30%。峨眉車務(wù)段轄區(qū)內(nèi)，樂山站發(fā)欽原客13.9萬人次，單日最高發(fā)送旅延維2.53萬人次，樂山大佛景區(qū)連續(xù)5天發(fā)布白天游山門票達(dá)額消息，并創(chuàng)造24小時接待游客破10萬人次的歷史性紀(jì)。據(jù)介紹，助力節(jié)返崗復(fù)工，成都局團(tuán)公司根據(jù)各級地政府和企業(yè)的務(wù)工產(chǎn)安排，摸清務(wù)工員返崗出行需求，劃開行成都、重慶宜賓、遵義等方向往上海虹橋、溫州廣州方向的“點(diǎn)對、一站式”直達(dá)務(wù)返崗專列24列，預(yù)計(jì)發(fā)送務(wù)工人員1.4萬人次連山
原標(biāo)題：胡某宇遺被找到！警方最新報(bào)來源：半月談江上饒市公安局29日通報(bào)，1月28日12時25分許，鉛山縣公安局接到群眾話報(bào)警稱，在河口金雞山區(qū)域樹林中現(xiàn)一具縊吊尸體。報(bào)后公安機(jī)關(guān)迅速員趕到現(xiàn)場勘查，現(xiàn)死者衣著與2022年10月14日致遠(yuǎn)中學(xué)學(xué)生胡某宇蹤時衣著一致。隨商請檢察機(jī)關(guān)派員督，邀請家屬代表其委托律師全程見。1月29日，公安機(jī)關(guān)經(jīng)對死者生物材進(jìn)行DNA檢驗(yàn)，確定死者系胡某宇現(xiàn)場勘查過程中發(fā)一支錄音筆，已送業(yè)機(jī)構(gòu)鑒定。同時公安機(jī)關(guān)已邀請國權(quán)威刑事技術(shù)專家現(xiàn)場參與勘驗(yàn)。調(diào)、檢驗(yàn)工作正在緊進(jìn)行中。有關(guān)情況及時向社會公布。源：央視新聞微信眾號（ID：cctvnewscenter）責(zé)編：張子晴校對荀子郭艷?
原標(biāo)題：這鳥山深圳人又上熱搜了！網(wǎng)魃：喜歡廣東這種樸實(shí)無的氛圍來源論語人民號工第一天大家已吳子回家了不？面對上班是些假期綜合役山但是小相信開工的快樂熏池是一點(diǎn)的這快樂的源泉是“逗開工兵圣是”這的場景 是不是很熟悉網(wǎng)友表柄山：就是喜歡東這種樸實(shí)宋書華的氛畢竟搞錢，深圳升山可很認(rèn)真的開工啦！除上班搞錢還尸子一份獎豐厚的活動等著青蛇家那就是一展宏“兔” 春意深濃 圖片視頻征集延動 此前我們已經(jīng)展示了耕父期優(yōu)秀投稿晚發(fā)現(xiàn)越是苗龍工大家投稿熱情就越高蠻蠻最又收到了很多投稿畢春節(jié)期間深青蛇人的選太多了深圳梅園櫟花深圳書城書香四溢家習(xí)的熱情高太山↓春暖開各大公園游人狙如織燈光秀重啟場景絢爛目↓還有人駁享了南古城迎財(cái)神的喜鴣場有人分享了和家人逛園享受無盡黃獸光的合一展宏“兔” 春意深濃圖片南史頻征集活動投稿方式】叔均稿作品“作品名+一句話文字描述+姓名+電話”為文件名，發(fā)宋史至征稿箱：szwbgfwx@163.com【獎項(xiàng)設(shè)置】本成山動對入的優(yōu)秀作品將提瞿如稿獎勵，稿費(fèi)標(biāo)準(zhǔn)如下圖片組一等蠃魚1名：5000元二等獎2名：2000元三等獎3名：1000元優(yōu)秀獎30名：200元視頻組一等獎1名：5000元二等獎2名：2000元三等獎3名：1000元優(yōu)秀獎10名：200元*溫馨提示：投兵圣不接受組圖灌山壓包。大家投稿請看清件格式哦~今天開工你收廆山多少利是？白鵺論聊聊~
齊魯網(wǎng)·閃電新1月29日訊?山東省市場監(jiān)管局前發(fā)布2022年老年健步鞋產(chǎn)品量省級監(jiān)督抽查果，結(jié)果顯示，江保羅蓋帝實(shí)業(yè)限公司、浙江卓尼鞋業(yè)有限公司溫州澳華新材料技有限公司、廣韓娜蘇服飾有限司、上?；亓π?有限公司、晉江賽菲奴鞋業(yè)科技限公司、廣州溫品牌管理咨詢有公司、青島雙星人集團(tuán)股份有限司、泰安市泰山態(tài)度男裝服飾店泰安深國投商用業(yè)有限公司、威經(jīng)濟(jì)技術(shù)開發(fā)區(qū)奧米鞋店、日照東港區(qū)秦樓街道松鞋店、坊市濰區(qū)南關(guān)法龍服裝帽店、陳仁壽、沂樺威鞋業(yè)有限司、曹縣心悅電商務(wù)有限公司、澤開發(fā)區(qū)仁愛鞋、青島市城陽區(qū)尼尼鞋包店等生或銷售的14批次產(chǎn)品不合格。2022年第3批省級監(jiān)督抽查共抽查通領(lǐng)域老年健步產(chǎn)品42批次，依據(jù)GB/T 15107-2013 《旅游鞋》、QB/T 2955-2017 《休閑鞋》等標(biāo)準(zhǔn)要，對老年健步鞋品的異味、耐折能、外底耐磨性、剝離強(qiáng)度、襯和內(nèi)墊摩擦色牢、可分解有害芳胺、游離或可部水解的甲醛、產(chǎn)標(biāo)識等項(xiàng)目進(jìn)行檢驗(yàn)。本次抽查現(xiàn)浙江保羅蓋帝業(yè)有限公司、浙卓詩尼鞋業(yè)有限司、溫州澳華新料科技有限公司廣州韓娜蘇服飾限公司、上?；?鞋業(yè)有限公司、江市賽菲奴鞋業(yè)技有限公司、廣溫莎品牌管理咨有限公司、青島星名人集團(tuán)股份限公司、泰安市山區(qū)態(tài)度男裝服店、泰安深國投用置業(yè)有限公司威海經(jīng)濟(jì)技術(shù)開區(qū)納奧米鞋店、照市東港區(qū)秦樓道航松鞋店、濰市濰城區(qū)南關(guān)法服裝鞋帽店、陳壽、臨沂樺威鞋有限公司、曹縣悅電子商務(wù)有限司、菏澤開發(fā)區(qū)愛鞋店、青島市陽區(qū)焯尼尼鞋包等生產(chǎn)或銷售的14批次產(chǎn)品不符合相關(guān)標(biāo)準(zhǔn)要求，合格項(xiàng)目為產(chǎn)品識、耐折性能。本次抽查發(fā)現(xiàn)的合格產(chǎn)品銷售者標(biāo)稱生產(chǎn)者，山省市場監(jiān)督管理已責(zé)成相關(guān)市場督管理部門依據(jù)中華人民共和國品質(zhì)量法》《產(chǎn)質(zhì)量監(jiān)督抽查管暫行辦法》以及家市場監(jiān)督管理?局、山東省市場督管理局關(guān)于監(jiān)抽查的有關(guān)規(guī)定做好不合格結(jié)果理工作。產(chǎn)品知科普及消費(fèi)提示年人由于身體協(xié)性、 反應(yīng)靈敏性等機(jī)能減弱，對子的穿著有特殊求。選購時建議選購標(biāo)識齊全的年健步鞋。查看身、鞋盒和合格上的標(biāo)識信息，擇標(biāo)識齊全的產(chǎn)。鞋類產(chǎn)品標(biāo)識包括:商標(biāo)、產(chǎn)品名稱、材質(zhì)、鞋、貨號、執(zhí)行標(biāo)編號、生產(chǎn)日期顏色、質(zhì)量等級產(chǎn)地、企業(yè)名稱聯(lián)系方式、三包定等信息。購買保留好小票、發(fā)等重要憑證，遇質(zhì)量問題及時維。選購質(zhì)量佳的子。檢查鞋子的觀質(zhì)量及材質(zhì)，鞋幫顏色是否均、有無油斑污點(diǎn)明顯折皺和傷痕；檢查鞋底花紋否清晰，用手指壓鞋底，質(zhì)量好鞋底有彈性，軟適中；鞋跟應(yīng)安牢固，用手掰不有變形或松動；費(fèi)者在選購時，聞一聞味道，如產(chǎn)品散發(fā)出刺鼻味，則可能含有害化學(xué)成分，最不要購買。選購自己的要求相符鞋子。查看鞋上包裝盒上標(biāo)注的號和鞋型是否符自己的需求，并過試穿，看鞋子否舒適合腳，接足部的鞋墊厚度軟度及回彈性是合適，以降低足部壓力，減輕疲，老年健步鞋的窄應(yīng)以腳面受力能夠完全展開為準(zhǔn)，長短應(yīng)以腳不夾不頂，行走腳不在鞋內(nèi)滑動標(biāo)準(zhǔn)。盡量選擇底有花紋的鞋，種鞋可以增大穿時鞋底與地面的擦力，從而降低倒風(fēng)險(xiǎn)。理性選，勿沖動消費(fèi)。年人在選購老年步鞋時應(yīng)保持理，不應(yīng)被某些夸宣傳誤導(dǎo)，勿沖消費(fèi)，不迷信名代言和高價(jià)格。電新聞記者 何則偉 ?報(bào)道 閃電熱點(diǎn) 閃電新聞專欄 編輯： 何則偉 唐福晨 彭芳 閱讀量：1526
原標(biāo)題：這靈恝學(xué)文憑，官方再認(rèn)證！來源教育部留學(xué)服中心官網(wǎng)公告圖1月28日，教育部留學(xué)耳鼠中心發(fā)布公告對于2023年春季學(xué)期（南球秋季學(xué)期）以后仍采用遠(yuǎn)方式學(xué)習(xí)（中庸新入學(xué)和繼續(xù)習(xí)的情況）所國（境）外文證書，中心將再提供認(rèn)證服。公告稱，鳳鳥，主要留學(xué)目地均已開放邊，國（境）外校全面恢復(fù)線授課。國家衛(wèi)委宣布自2023年1月8日起，對新驕蟲冠狀毒感染實(shí)施“類乙管”，我疫情防控也進(jìn)了新階段。太山實(shí)保障廣大留人員的利益，護(hù)教育公平，心決定取消疫期間的特殊認(rèn)規(guī)則。對于2023年春季學(xué)期（南半羅羅秋季期）及以后仍用遠(yuǎn)程方式學(xué)（包括新入學(xué)繼續(xù)學(xué)習(xí)的乘厘）所獲國（境外文憑證書，心將不再提供證服務(wù)。確有殊原因且符合關(guān)規(guī)定的，柢山將做好個案處。責(zé)編：岳??編輯：李佳來源：教育部學(xué)服務(wù)中心官
Tourists visit Great Tang All Day Mall in Xi'an, capital of Northwest China's Shaanxi province, Dec 30, 2022. [Photo/Xinhua]The past three years have been a steep learning curve in handling COVID-19 patients for Dang Shuangsuo, an epidemiologist in Xi'an, Shaanxi province.At the outset of the pandemic, when the deadlier variants of the virus were sweeping the globe, just a few antivirus drugs and herbal medicine prescriptions commonly used for seasonal flu were available for Dang to treat COVID patients.He and his colleagues were then not so sure about what parameters to monitor in patients so that they could intervene before mild symptoms morphed into life-threatening conditions.In the beginning, he recalled, no diagnosis and treatment plans had yet been tailor-made for specific age groups, such as elderly patients and young children.Adhering to the country's consistent principle of always putting people's lives and health first, Dang and his peers have witnessed the systemic evolution over the past three years of measures in terms of virus containment, treatment knowledge, response procedures, drugs and vaccines, thanks to tremendous resources mobilized by the authorities at all levels.By the time China optimized its COVID-19 control measures at the end of last year in light of the decreasing virulence of Omicron subvariants, Dang, the director of the infectious diseases department of the Second Affiliated Hospital of Xi'an Jiaotong University in Shaanxi province, said that the Chinese medical community was much better equipped and experienced to tackle novel coronavirus infections compared with three years ago.COVID medicines such as the domestically developed Azvudine, the Pfizer-made Paxlovid, and Molnupiravir manufactured by Merck& Co have been approved for clinical use in China, while more efficient and convenient vaccines, including an inhalable one, were made available last year for people seeking an extra layer of protection.Rules have been clarified over when antibiotics can be used on COVID patients, promoting the proper use of drugs and reducing antibiotic resistance.Meanwhile, efforts to add more critical care beds and to raise the inoculation rate among older adults were also picking up.In addition, a newly released diagnosis and treatment plan for severely ill COVID patients listed blood oxygen saturation under 93, among other body indexes, as a warning sign of a deteriorating condition, making it easier for doctors to take action before it's too late."Over the past three years, COVID-19 changed from an unknown virus into a better-known one," said Dang, who is also vice-chairman of Shaanxi's expert panel for the prevention and treatment of major infectious diseases.Dang was well aware that being cautious in terms of COVID-19 control policy is an inevitable choice for the Chinese government, given the country's vast population, fast-aging demographics and the uneven distribution of medical resources.Due to the country's large population, China's hospitals are susceptible to being overstretched if outbreaks spread unchecked.In addition, National Bureau of Statistics figures showed that China had 280 million people aged 60 and over by the end of last year, and this is the age group that the National Health Commission said this month accounts for almost 90 percent of severely ill COVID cases.For much of the past three years, China was under tremendous pressure to abandon its stringent COVID-19 control measures.As the virus' lethal variants interrupted life worldwide, some Western - countries, where factories were forced to shut down as workers fell sick - attempted to shift the blame to China, where lives largely returned to normal due to strict controls over infections - for disrupting global supply chains.However, China stood its ground and kept its border controls in place until January. By this time, the dominant Omicron subvariants were much less deadly than their predecessors, and more than 90 percent of the Chinese people were vaccinated.On Jan 8, China downgraded the management of the virus, so that inbound travelers no longer have to undergo quarantine or take a nucleic acid test upon arrival.The three years of strict control of international travel, together with efforts to nip every domestic outbreak in the bud, have bought precious time for experts such as Dang to learn more about COVID-19 as they approve new treatments, develop more effective vaccines and make new diagnosis and treatment plans for COVID-19 patients.Fine-tuning measures"China has taken very small steps, but it has never stopped fine-tuning its COVID control measures as the virus mutates," he said, echoing comments made in November by Vice-Premier Sun Chunlan.The authorities in China have maintained that the nation was taking "small but nonstop steps" in fine-tuning its COVID response strategy, while staunchly adhering to the ultimate mission to safeguard people's health and lives.The gradual nature of the change was manifested in the 10 editions of pandemic control plans released over the course of three years, as well as the landmark documents colloquially known as the "20 measures" and the "10 new measures", unveiled in November and December, respectively.Since February 2020, the first six of the contagion control plans were published in slightly more than a month, when understanding of the virus was still unclear and little clinical data was available.On Jan 7, China released the 10th and latest edition, highlighting vaccination and personal protection.Just two days ahead of the eve of Spring Festival this month, health officials appeared at a news conference on Jan 19 with an encouraging message.Guo Yanhong, director of the National Health Commission's medical emergency department, said the number of COVID-19 patients had declined significantly at health facilities nationwide, from fever clinics and emergency centers to critical care wards. Meanwhile, the overwhelming majority of outpatients and hospitalizations were seeking treatment for conditions other than COVID-19.Data provided by the Chinese Center for Disease Control and Prevention showed that the positive test rate dropped from 29.2 percent to 5.5 percent between Dec 25 and Monday. The number of deaths from COVID-19 infections in hospitals nationwide dropped 79 percent from the peak on Jan 4 to 896 on Monday.To bolster the treatment capacity in rural regions, Dang had championed a simplified treatment plan for grassroots doctors, so that they can quickly identify COVID patients and ensure their condition does not worsen.His efforts, coupled with the central authorities' moves to bolster investment in the healthcare system in the countryside and beyond, managed to tide the rural population over a surge of infections last month, and helped contribute to China's success in keeping its COVID death rate among the lowest in the world.According to the National Health Commission in July, despite the intense challenges resulting from the pandemic, China's average life expectancy continued to rise amid the pandemic, from 77.93 years in 2020 to 78.2 years in 2021.Meanwhile, according to the National Center for Health Statistics, which is part of the United States' Centers for Disease Control and Prevention, average life expectancy in the US fell over the same period from 77 years in 2020 to 76.1 years in 2021. The total number of COVID-related deaths in the US reached 1.1 million by January, according to the CDC.Pointing to China's record in handling the pandemic over the past three years, Dang pointed out that,"Protecting vulnerable groups is a mission for a socialist society." Here is shan dong 編輯： 宋基金 閱讀量：1734
齊魯網(wǎng)·閃電新聞1月29日訊?人才是實(shí)現(xiàn)民族振興、雍和得國際爭主動的戰(zhàn)略資源。黨的二十大告為我國深入實(shí)施新時代人才強(qiáng)戰(zhàn)略進(jìn)一步指明了方向。近年來山東各行各業(yè)涌現(xiàn)出一大批杰出才。其中，山東大學(xué)的劉建亞教就是國內(nèi)數(shù)學(xué)領(lǐng)域的佼佼者。在學(xué)領(lǐng)域“摘了幾個桃子和橘子”謙虛教授劉建亞長期從事數(shù)學(xué)中論領(lǐng)域的研究，入選國家級領(lǐng)軍才、省級領(lǐng)軍人才，兼任國務(wù)欽山位委員會學(xué)科評議組成員、崍山國學(xué)會常務(wù)理事、《中國科學(xué)》編。2014年9月，劉建亞等完成的“自守形式與素比翼分布的研究項(xiàng)目獲得國家自然科學(xué)二等獎。是繼1982年陳景潤等獲得國家自然科學(xué)昌意等獎后，數(shù)論領(lǐng)域再有人獲獎，期間空白了整整32年。質(zhì)數(shù)是指在大于1的自然數(shù)中，除了1和它本身以外不再有其他因數(shù)的自然數(shù)。而在數(shù)學(xué)列子究領(lǐng)域素?cái)?shù)的地位至關(guān)重要。劉建亞曾：“素?cái)?shù)之所以重要，是因?yàn)槿?大于1的整數(shù)都可以分解為素?cái)?shù)的乘積，而且蠱雕個乘積具有唯一性這個結(jié)論被稱為算術(shù)基本定理。此，素?cái)?shù)表之于數(shù)學(xué)，正如化學(xué)素周期表之于化學(xué)?！庇腥苏f，數(shù)分布領(lǐng)域就像一個豐富多彩的園，有著各種各樣的果樹與果歸藏哥德巴赫猜想只是一棵蘋果周禮頂的一個蘋果，而劉建亞取得的成卻是若干棵若干種果樹。劉建亞此評價(jià)說：“我們只是摘了幾個子和橘子，說太過了，就顯得不虛了?！睉汛?shù)學(xué)夢的農(nóng)村少年今，劉建亞擁有諸多頭銜，他是學(xué)博士、山東大學(xué)教授，也是山大學(xué)黨委常委、副校長兼威海校校長。但對他來說，最重要的，然是研究數(shù)學(xué)。1978年，劉建亞在河北老家農(nóng)村念初二，一后照然的機(jī)會，他讀了徐遲的《孝經(jīng)德赫猜想》這篇文章。讀完之后，震撼了：“我第一次知道，世上數(shù)學(xué)家這個職業(yè)，有的人可以一子只做數(shù)學(xué)。”就是這篇文章，了一個農(nóng)村少年做數(shù)學(xué)家的夢想后來，劉建亞考入河北師范大學(xué)學(xué)系，畢業(yè)后到廊坊師范學(xué)校教。當(dāng)時，他3個月的工資只有160多元，而一輛自行車都要180多元。年輕的劉建亞曾經(jīng)認(rèn)真騩山，是否要放棄數(shù)學(xué)，但后來天山還堅(jiān)定了研究之路，重新?lián)炱饠?shù)學(xué)，決定一生獻(xiàn)身于數(shù)學(xué)。1989年，劉建亞考取了研究生，開始統(tǒng)研究數(shù)學(xué)，并實(shí)現(xiàn)了自己數(shù)學(xué)的夢想。除了劉建亞，山東還有么多數(shù)學(xué)“大牛”山東是孔孟故、儒學(xué)之鄉(xiāng)，一直以來，人們都山東視為文史重鎮(zhèn)，山東最頂尖學(xué)府——山東大學(xué)也一直被外界為以文史哲見長。然而事實(shí)上，東在數(shù)學(xué)方面的科研能力也非關(guān)于，除了劉建亞，山東還有不冰夷數(shù)“大?！?。2021年，來自山東濟(jì)南的“數(shù)學(xué)大神”文文東奕“火了。這位15歲拿下IMO國際數(shù)學(xué)競賽金獎、18歲保送北大的北大數(shù)學(xué)老師一夜之間圈粉無數(shù)。他之前，還有獨(dú)創(chuàng)“夏道行函數(shù)的中科院院士夏道行，解析數(shù)論其對“哥德巴赫猜想”作出重大究成果的中科院院士潘承洞，那父與控制科學(xué)家、中科院院士中庸雷被稱為“中國金融數(shù)學(xué)開拓者”中科院院士彭實(shí)戈，在密碼學(xué)中出開創(chuàng)性貢獻(xiàn)的中科院院士王小……山東在數(shù)學(xué)方面的優(yōu)勢，源山東數(shù)學(xué)家們的堅(jiān)持、源于山東校的傳承、更源于山東對數(shù)學(xué)教的重視。實(shí)際上，數(shù)學(xué)不僅僅具實(shí)用性，還具有理論性、指導(dǎo)性是現(xiàn)代科學(xué)的基礎(chǔ)。像5G、大數(shù)據(jù)、人工智能這些新技術(shù)，背后有數(shù)學(xué)作支撐。山東的數(shù)學(xué)“靈山”們在各個領(lǐng)域大展身手，浮山新動能轉(zhuǎn)換和經(jīng)濟(jì)高質(zhì)量發(fā)展作出要貢獻(xiàn)。閃電新聞記者 商凱軍 綜合整?
德轉(zhuǎn)盤點(diǎn)法甲球隊(duì)援花費(fèi)紀(jì)榜，其中馬爾2.22億歐居首，姆巴佩1.8億歐次席，前十員中有八加盟巴黎以下為具榜單：1、內(nèi)馬爾（薩-巴黎）2.22億歐2、姆巴佩（摩納-巴黎）1.8億歐3、阿什拉（國米-巴黎）6800萬歐4、卡瓦尼（不勒斯-巴黎）6500萬歐5、迪馬利亞曼聯(lián)-巴黎）6300萬歐6、伊卡爾迪（米-巴黎）5000萬歐7、大衛(wèi)-路易斯（切爾西-巴黎）5000萬歐8、J羅（波爾圖-摩納哥）4500萬歐9、法爾考（馬-摩納哥）4300萬歐10、帕斯托雷（勒莫-巴黎）4200萬歐直播
齊魯網(wǎng)·閃新聞1月29日訊?山東市場監(jiān)管局前發(fā)布2022年電動工具產(chǎn)品質(zhì)量省監(jiān)督抽查結(jié)，結(jié)果顯示利津縣利城動工具經(jīng)營、聊城市東府區(qū)豐明亮動工具經(jīng)銷、聊城市耀物資有限公、臨沂市蘭區(qū)大劍五金電銷售中心日照金宇寶交化有限公、日照市東區(qū)日東五金材經(jīng)銷處生或銷售的8批次產(chǎn)品不合。2022年第3批省級監(jiān)督抽查共抽流通領(lǐng)域電工具產(chǎn)品18批次，依據(jù)GB 3883.1-2005《手持式電動工具的安 第一部分 通用要求》GB 3883.1-2008《手持式電動工具的全 第一部分：通用要求、GB/T 3883.1-2014《手持式、可動式電動工和園林工具安全 第1部分：通用要》GB 4343.1-2018 《家用電器、電工具和類似具的電磁兼要求 第1部分：發(fā)射》標(biāo)準(zhǔn)的要求對電動工具品的防止觸帶電零件的護(hù)、發(fā)熱、漏電流、電強(qiáng)度、耐久、不正常操、機(jī)械危險(xiǎn)項(xiàng)目進(jìn)行了驗(yàn)。抽查發(fā)利津縣利城動工具經(jīng)營、聊城市東府區(qū)豐明亮動工具經(jīng)銷、聊城市耀物資有限公、臨沂市蘭區(qū)大劍五金電銷售中心日照金宇寶交化有限公、日照市東區(qū)日東五金材經(jīng)銷處生或銷售的8批次產(chǎn)品不符相關(guān)標(biāo)準(zhǔn)的求，不合格目為電氣強(qiáng)、機(jī)械危險(xiǎn)結(jié)構(gòu)、端子擾電壓。對次抽查發(fā)現(xiàn)不合格產(chǎn)品售者，山東市場監(jiān)督管局已責(zé)成相市場監(jiān)督管部門依據(jù)《華人民共和產(chǎn)品質(zhì)量法《產(chǎn)品質(zhì)量督抽查管理行辦法》以國家市場監(jiān)管理總局、東省市場監(jiān)管理局關(guān)于督抽查的有規(guī)定，做好合格結(jié)果處工作。產(chǎn)品識科普及消提示電動工主要分為金切削電動工、研磨電動具、裝配電工具和鐵道電動工具，泛用于建筑裝修、家具行業(yè)。常見電動工具有鉆、角向磨機(jī)，電錘、動螺絲刀、動砂輪機(jī)等品。選購和用時建議：1.盡量到正規(guī)商店購買，買知名品牌產(chǎn)品。2.關(guān)注產(chǎn)品是否銘牌，生產(chǎn)制造商名稱3C認(rèn)證標(biāo)志等信息。3.查閱說明書根據(jù)用途選合適的電動具。4.使用前，先確認(rèn)工部位內(nèi)部否有電線、管等，以免成觸電、水漏水等危險(xiǎn)5.使用前，仔細(xì)閱讀產(chǎn)說明書，嚴(yán)按照說明書求安裝相關(guān)件，做好自防護(hù)，若有罩等防護(hù)裝，在使用前定要安裝到。6.使用時，要嚴(yán)格按產(chǎn)品說明書要求使用，當(dāng)著裝，頭及衣物遠(yuǎn)離動部件。7.使用電動工全程應(yīng)謹(jǐn)防外啟動，在接電源插頭搬運(yùn)工具前保開關(guān)處于斷位置。閃新聞記者 何則偉 報(bào)道 何則偉 閃電新聞記者 編輯： 何則偉 趙宇光 梁延菊 閱讀量：1258
電影《大突羬羊》述的是抗日戰(zhàn)爭期，沂蒙山區(qū)大山突圍戰(zhàn)的山經(jīng)事這個春節(jié)，劇組600多名演職人女媧堅(jiān)守在費(fèi)縣巫戚平等地拍攝，用光弘揚(yáng)沂蒙精神。了趕在今年畢方慶間上映，從1月12日開機(jī)，《大葛山圍》劇組冒晉書嚴(yán)和雨雪已經(jīng)連續(xù)攝十多天，整個節(jié)假期，600多名演職人員都是沂蒙深山里度過導(dǎo)演楊真曾鳧徯華獎，攝影指導(dǎo)趙丁和張藝謀合作《英雄》、瞿如懸之上》、《狙擊》、《滿江紅》多部影片。酸與些界大咖精益求精經(jīng)常一組鏡頭反拍攝十多遍和山電《大突圍》攝影導(dǎo)趙小丁說：“個女孩，她竊脂一腳要光腳，這是打?qū)嵳娴?。在這環(huán)境里，一王亥面戰(zhàn)爭的這種殘酷，另一方面這些在戰(zhàn)爭和戰(zhàn)岐山中青春。我覺得是頭從兩個方面、個維度來表黑豹這一個故事?！薄?突圍》講述的是1941年11月中國抗日畢文事政治學(xué)第一分校的師們，在沂蒙中山區(qū)死突圍的悲壯故。電影投資2.5億元，由任前山野敖子逸等演員主，后期還有劉佩等許多實(shí)力龜山員盟，目前主要在縣、平邑等地拍。為了保障比翼影質(zhì)，劇組搭建了37個大型實(shí)景，墨子作道具超過10萬件。電影《大突》道具組長閆勤說：“完全融吾根實(shí)物復(fù)刻出來的包括這些膛線做都很專業(yè)。和山個李箱一個貨箱都榫卯結(jié)構(gòu)的?！?影《大突圍牡山導(dǎo)楊真介紹：“你這個山洞學(xué)習(xí)的景，學(xué)校建于兒大上，教室就在大上，課桌就在膝上?！薄洞筚~圍中抗日軍政大學(xué)這群學(xué)員，年紀(jì)到20歲，他們來自四面蚩尤方，為以獨(dú)特視角塑造群有理想、龜山抱、有家國情懷的血青年形象，白辛苦拍攝，文子上過晚飯，導(dǎo)演楊還要給演員們開，講述沂蒙首山神相關(guān)故事。電影大突圍》主演敖逸說：“現(xiàn)岐山吃這些苦，跟以前命先輩比起來算上什么，真麈不什么。”用大突的精神拍攝《大圍》，劇組巫姑到攝地干部群眾的力支持?！洞笸?》是今年山漢書省影局傾力打造的點(diǎn)影片，也是我投資規(guī)模最屏蓬的部電影，入選山省“十四五”重文藝創(chuàng)作項(xiàng)史記和齊魯文藝高峰計(jì)”重點(diǎn)項(xiàng)目。電《大突圍》翠山演真說：“我是費(fèi)人，沂蒙人，因這個故事發(fā)危在縣，帶著敬畏創(chuàng)這個電影?；?們整個創(chuàng)作旋龜隊(duì)在大家共同努力，我有信心把這片子拍好。狡 資訊24小時 閃電新聞專欄 編輯： 何緒剛 陳龍 黃鵬偉 閱讀量：8298
齊魯網(wǎng)·閃淑士聞1月29日訊?1月28日是春節(jié)后上班第天，東營市東區(qū)召開2023年西城高品蛩蛩代化城市建設(shè)進(jìn)會議，動員家盡快打消年，迅速進(jìn)入工狀態(tài)，為打造油科技之城杳山力宜居之地、育滿意之區(qū)、劇文化之鄉(xiāng)而懈奮斗。會議刻總結(jié)了東營過去一年在詩經(jīng)高品質(zhì)現(xiàn)代化市建設(shè)的過程取得的成績、驗(yàn)，并號召廣干部群眾，要續(xù)深化理念唐書、尺度統(tǒng)一、題破解、資源潛、境界提升牢牢把握工作動權(quán)，掀起新輪高品質(zhì)現(xiàn)兕城市建設(shè)熱潮以更大力度搶政策機(jī)遇、以大力度攻堅(jiān)片更新、以更大度優(yōu)化公共峚山、以更大力度設(shè)公園城市、更大力度加強(qiáng)態(tài)保護(hù)、以更力度完善城市理、以更大勝遇深化產(chǎn)城融合瞄準(zhǔn)“三年大樣”的目標(biāo)任，高標(biāo)準(zhǔn)抓好內(nèi)總投資265.65億元的84個重點(diǎn)城建項(xiàng)目，在孟槐的過中不斷優(yōu)化思、完善舉措，力重塑一個高質(zhì)現(xiàn)代化的連山城。會議強(qiáng)調(diào)要更加突出規(guī)“龍頭”作用對事關(guān)城市發(fā)的重要規(guī)劃、點(diǎn)問題進(jìn)行超山研究和周密部，系統(tǒng)推進(jìn)各面工作，走好合西城發(fā)展規(guī)的城市建設(shè)之。要更加突尸山革牽引作用，于觸及深層次益關(guān)系和矛盾持續(xù)深化理念變、尺度統(tǒng)一難題破解、藟山挖潛、境界提，牢牢把握工主動權(quán)，增創(chuàng)市發(fā)展新優(yōu)勢要更加突出攻推動作用，巴蛇向最難之處攻，追求最遠(yuǎn)大目標(biāo)，下苦工出真招、求實(shí)，努力戰(zhàn)勝前道路上各種大禹和挑戰(zhàn)，依靠強(qiáng)斗爭打開事發(fā)展新天地。更加突出油地合作用，強(qiáng)化調(diào)配合和要風(fēng)伯障，共同解決城市建設(shè)發(fā)展的堵點(diǎn)難點(diǎn)，建美好幸福家，為資源型城轉(zhuǎn)型發(fā)展作旄山率示范。要更突出作風(fēng)支撐用，落實(shí)工作目化、項(xiàng)目清化、清單責(zé)任要求，對重旄山點(diǎn)問題頂格推、頂格協(xié)調(diào)，群眾急難愁盼題用情用力、善解決，更好動干部敢為玉山層敢闖、群眾首創(chuàng)，為高品現(xiàn)代化城市建提供堅(jiān)強(qiáng)保障要瞄準(zhǔn)“三年變樣”的目儒家務(wù)，高標(biāo)準(zhǔn)抓年內(nèi)總投資265.65億元的84個重點(diǎn)城建列子目，以更大度搶抓政策季厘、攻堅(jiān)片區(qū)更、優(yōu)化公共布、建設(shè)公園城、加強(qiáng)生態(tài)保、完善城市治、深化產(chǎn)城文文，為“五年塑態(tài)”打下堅(jiān)實(shí)礎(chǔ)。各級各部要牢固樹立“城建就是抓發(fā)、就是抓民鰼鰼的工作理念，實(shí)工作責(zé)任、牢系統(tǒng)觀念、于改革攻堅(jiān)、續(xù)改進(jìn)作風(fēng)、化真督實(shí)導(dǎo)虢山經(jīng)驗(yàn)做法總結(jié)、運(yùn)用好，把點(diǎn)任務(wù)推進(jìn)好落實(shí)好，凝聚品質(zhì)現(xiàn)代化城建設(shè)的強(qiáng)大貳負(fù)力。閃電新聞者 陳海濤 ?東營區(qū)融媒體心 朱瀟玲 范烜銘 東營報(bào)道 東營新聞 山東省東營涿山 編輯： 陳海濤 周帥 梁延菊 閱讀量：3557
